Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Recent data demonstrate that acute central administration of 5 g of the centrally selective TGR5 agonist, 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-4-isoxazolecarboxamide, significantly reduces body weight gain in mice
Your liver is like a hardworking friend who deserves all the support you can giveand that means looking beyond just IV therapy
The primary signs of a compromised peptide are changes in appearance
Health system specialty pharmacies can work directly with insurers to reduce delays and out-of-pocket expenses
GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk in IBD Populations Cancer Network Staff Tim Cortese , Russ Conroy Retrospective data showed that GLP-1 receptor agonist use was associated with a 51% reduction in colorectal cancer odds among patients with inflammatory bowel disease
Management of status epilepticus in adults
US$ 21.34
US$ 26.83
US$ 20.74
